NMD Pharma A/S — Credit Rating and Financial Key Figures

NMD Pharma A/S (CVR number: 36899069) is a company from AARHUS. The company recorded a gross profit of -19182.1 kEUR in 2023. The operating profit was -23.2 mEUR, while net earnings were -22.4 mEUR. The profitability of the company measured by Return on Assets (ROA) was -62.9 %, which can be considered poor and Return on Equity (ROE) was -66.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 92 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. NMD Pharma A/S's liquidity measured by quick ratio was 12.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.